| Accelerate Resources Limited (AX8) ORDINARY FULLY PAID |
Materials |
$7 |
Shares Issued and Cleansing Notice
|
10 Feb 2025 9:04AM |
$0.011 |
$0.009 |
fallen by
18.18%
|
|
| Chimeric Therapeutics Limited (CHM) ORDINARY FULLY PAID |
Health Care |
$8 |
UChicago Medicine joins CHM CDH17 trial
|
10 Feb 2025 9:01AM |
$0.007 |
$0.004 |
fallen by
42.86%
|
|
| Red Metal Limited (RDM) ORDINARY FULLY PAID |
Materials |
$41 |
Sybella REO Infill Drilling Confirms Continuity
|
10 Feb 2025 9:00AM |
$0.115 |
$0.115 |
fallen by
0%
|
|
RDM - Price-sensitive ASX Announcement
Full Release
Key Points
- Infill drilling at Sybella confirms continuity of rare earth oxide mineralisation.
- Assays from 19 holes reveal significant neodymium and praseodymium grades.
- Drill intercepts include multiple long intervals starting from surface.
- Total MREO grades and widths consistent with earlier traverses.
- Ongoing pH optimisation leach tests with results expected in March 2025.
- Plans for further infill drilling to upgrade mineral resource category.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AKORA Resources Limited (AKO) ORDINARY FULLY PAID |
Materials |
$13 |
Placement Cleansing Notice
|
10 Feb 2025 9:00AM |
$0.120 |
$0.095 |
fallen by
20.83%
|
|
| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$177 |
Depth Extension Confirmed at Tunkillia Project 223 Deposit
|
10 Feb 2025 8:59AM |
$0.290 |
$0.795 |
risen by
174.14%
|
|
BGD - Price-sensitive ASX Announcement
Full Release
Key Points
- Depth extension confirmed at Tunkillia Project's 223 Deposit.
- Broad mineralisation intersected 50 – 100m below modelled pit floor.
- Updated Mineral Resources Estimate grew to 1.50Moz Au.
- Optimised Scoping Study ongoing with 5,064 metres reverse circulation drilling completed.
- Significant intersections include 10m @ 2.72 g/t Au from 144m and 20m @ 0.93 g/t Au from 339m.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Trek Metals Limited (TKM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$56 |
High-grade Manganese discovery at the Pearana prospect
|
10 Feb 2025 8:59AM |
$0.024 |
$0.095 |
risen by
295.83%
|
|
TKM - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade manganese discovery at Pearana, a high priority exploration target.
- Multiple assays exceed 30% Mn, with a peak assay of 51.8% Mn.
- Confirmed over a 3.5 km strike length.
- Strong results across four key prospects indicate high prospectivity.
- Key access agreements executed for heritage surveying and drilling.
- Next steps include drill targeting and geophysical surveys.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AKORA Resources Limited (AKO) ORDINARY FULLY PAID |
Materials |
$13 |
Application for quotation of securities - AKO
|
10 Feb 2025 8:59AM |
$0.120 |
$0.095 |
fallen by
20.83%
|
|
| Matsa Resources Limited (MAT) ORDINARY FULLY PAID |
Materials |
$48 |
Initial Substantial Shareholder Notice from PTN
|
10 Feb 2025 8:58AM |
$0.042 |
$0.066 |
risen by
57.14%
|
|
| Patronus Resources Limited (PTN) ORDINARY FULLY PAID |
Materials |
$108 |
Initial Substantial Shareholder Notice for MAT
|
10 Feb 2025 8:58AM |
$0.059 |
$0.066 |
risen by
11.86%
|
|
| Patronus Resources Limited (PTN) ORDINARY FULLY PAID |
Materials |
$108 |
Patronus Takeover Announcement and Bidders Statement
|
10 Feb 2025 8:58AM |
$0.059 |
$0.066 |
risen by
11.86%
|
|
PTN - Price-sensitive ASX Announcement
Full Release
Key Points
- Patronus offers A$0.045 cash per share for all Matsa shares.
- The offer represents a 12.5% premium to Matsa's last traded price before the announcement.
- Patronus holds a 19.57% interest in Matsa prior to the offer.
- The offer aims to provide immediate liquidity for Matsa shareholders.
- Patronus plans to potentially restructure Matsa's board and conduct a strategic review of its assets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Matsa Resources Limited (MAT) ORDINARY FULLY PAID |
Materials |
$48 |
PTN: Patronus Takeover Announcement and Bidders Statement
|
10 Feb 2025 8:58AM |
$0.042 |
$0.066 |
risen by
57.14%
|
|
MAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Patronus will acquire all Matsa Shares at A$0.045 cash per share.
- The announcement date of the offer is 10 February 2025.
- The offer represents a 12.5% premium to the last traded price on 6 February 2025.
- The offer period begins on 24 February 2025 and ends on 24 March 2025.
- Patronus holds a relevant interest in 19.57% of Matsa Shares prior to the offer.
- The offer is unconditional and fully funded from Patronus' cash reserves.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Patronus Resources Limited (PTN) ORDINARY FULLY PAID |
Materials |
$108 |
Announcement of On-Market Takeover Bid
|
10 Feb 2025 8:57AM |
$0.059 |
$0.066 |
risen by
11.86%
|
|
PTN - Price-sensitive ASX Announcement
Full Release
Key Points
- Announcement date is 10 February 2025.
- Patronus Resources Limited is making an on-market takeover bid.
- Offer price is A$0.045 cash per share.
- The offer is for up to 589,202,333 shares of Matsa Resources Limited.
- The offer is unconditional and will last until 24 March 2025.
- A Bidder's Statement is to be issued today.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Matsa Resources Limited (MAT) ORDINARY FULLY PAID |
Materials |
$48 |
PTN: Announcement of On-Market Takeover Bid
|
10 Feb 2025 8:57AM |
$0.042 |
$0.066 |
risen by
57.14%
|
|
MAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Announcement of on-market takeover bid by Patronus Resources Limited for Matsa Resources Limited.
- Offer price set at A$0.045 cash per share.
- Offer period from 24 February 2025 to 24 March 2025.
- Bidder seeks to acquire up to 589,202,333 shares.
- Offer is unconditional and payment will be made in cash.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$105 |
Notification of cessation of securities - CAM
|
10 Feb 2025 8:56AM |
$0.778 |
$0.705 |
fallen by
9.32%
|
|
| KKR Credit Income Fund (KKC) ORDINARY UNITS FULLY PAID |
Financials |
$735 |
Net Tangible Asset Backing
|
10 Feb 2025 8:56AM |
$2.380 |
$2.280 |
fallen by
4.20%
|
|
| NGX Limited (NGX) ORDINARY FULLY PAID |
Materials |
$11 |
Notice of General Meeting/Proxy Form
|
10 Feb 2025 8:56AM |
$0.145 |
$0.120 |
fallen by
17.24%
|
|
| Vanadium Resources Limited (VR8) ORDINARY FULLY PAID |
Materials |
$11 |
Voluntary Suspension - Extension
|
10 Feb 2025 8:56AM |
$0.029 |
$0.019 |
fallen by
34.48%
|
|
| Firetail Resources Limited (FTL) ORDINARY FULLY PAID |
Materials |
$32 |
Multiple Substantial EM Conductors Delineated at Skyline
|
10 Feb 2025 8:53AM |
$0.060 |
$0.084 |
risen by
40%
|
|
FTL - Price-sensitive ASX Announcement
Full Release
Key Points
- Multiple late channel bedrock EM conductors have been identified by the recent Heli EM survey across the Northern half of the Skyline Copper Project.
- This survey was the first modern airborne EM survey completed across the Skyline Project.
- Five new target areas have been identified with priority EM Plates.
- The Veyron Target comprises two modelled EM plates, each with a strike length of 500m and depth extent of 700m.
- Both plates have a conductivity response similar to known copper-zinc mineralisation.
- Follow-up ground EM will be conducted as a priority to refine the geometry and extent of the EM conductors.
- The Countach, Cayman, and Maranello Zones represent multiple discrete EM conductors along the western contact of the ophiolite sequence.
- Petrophysics based on high-grade diamond drill core aligns well with the conductivity response of modelled conductor plates.
- An airborne EM survey is planned to be conducted in Q2CY25 to test a further 9km of prospective VMS strike at Skyline.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WEB Travel Group Limited (WEB) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,572 |
Update - Notification of buy-back - WEB
|
10 Feb 2025 8:52AM |
$5.060 |
$4.350 |
fallen by
14.03%
|
|
| PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$741 |
Approval to Commence Human Trials in Kidney Program
|
10 Feb 2025 8:51AM |
$1.255 |
$1.270 |
risen by
1.20%
|
|
PYC - Price-sensitive ASX Announcement
Full Release
Key Points
- PYC Therapeutics has received approval to commence human trials for PYC-003.
- PYC-003 targets the underlying cause of Polycystic Kidney Disease (PKD).
- PKD is a life-changing condition affecting over 5 million people worldwide.
- The trials will be conducted in two parts: healthy volunteers and PKD patients.
- The disease leads to renal failure, with most patients requiring a kidney transplant by age 55.
- The trial design includes a Single Ascending Dose (SAD) study.
- Pre-clinical data supports the efficacy and safety of PYC-003.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Radiopharm Theranostics Limited (RAD) ORDINARY FULLY PAID |
Health Care |
$52 |
Clinical trial data shows RAD 101 detects Brain Metastases
|
10 Feb 2025 8:49AM |
$0.025 |
$0.022 |
fallen by
12%
|
|
RAD - Price-sensitive ASX Announcement
Full Release
Key Points
- RAD 101 detects brain metastases using novel imaging methodology.
- All brain metastases were detected, showing high tumor-to-background ratio.
- A Phase 2b study is recruiting participants in the United States.
- The study confirms earlier positive data from a Phase 2a trial.
- RAD 101 targets fatty acid metabolism, which is prominent in many solid tumors.
- The lead inventor emphasizes the need for improved detection of brain metastases.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$105 |
Update - Notification of buy-back - CAM
|
10 Feb 2025 8:48AM |
$0.778 |
$0.705 |
fallen by
9.32%
|
|
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$299 |
Weekly NTA Update
|
10 Feb 2025 8:48AM |
$2.170 |
$1.995 |
fallen by
8.06%
|
|
| Red Hawk Mining Limited (RHK) ORDINARY FULLY PAID |
Materials |
- |
Change of Director's Interest Notice - Steven Michael
|
10 Feb 2025 8:47AM |
$1.200 |
$1.200 |
fallen by
0%
|
|
| Bubalus Resources Limited (BUS) ORDINARY FULLY PAID |
Materials |
$6 |
Change of Director's Interest Notice - WO
|
10 Feb 2025 8:47AM |
$0.180 |
$0.100 |
fallen by
44.44%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
